Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 13, 2020

BUY
$34.44 - $43.75 $1.07 Million - $1.36 Million
31,000 Added 184.52%
47,800 $2.58 Million
Q2 2020

Aug 12, 2020

SELL
$27.12 - $45.97 $621,048 - $1.05 Million
-22,900 Reduced 57.68%
16,800 $1.03 Million
Q4 2019

Feb 12, 2020

BUY
$46.96 - $61.67 $1.26 Million - $1.66 Million
26,900 Added 210.16%
39,700 $3.48 Million
Q4 2018

Feb 13, 2019

BUY
$59.1 - $93.26 $756,480 - $1.19 Million
12,800 New
12,800 $1.27 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $485M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.